Cargando…
Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery
Femoral nerve palsy and meralgia paresthetica following gynecologic cancer surgery are rare, but severe and long lasting. Here, we aimed to study their incidence, severity, possible risk factors and its time to remission. Between January 2008 and December 2017 976 gynecologic cancer patients were id...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655817/ https://www.ncbi.nlm.nih.gov/pubmed/36362470 http://dx.doi.org/10.3390/jcm11216242 |
_version_ | 1784829279575474176 |
---|---|
author | Egger, Eva Katharina Sezer, Oezge Condic, Mateja Recker, Florian Marinova, Milka Hilbert, Tobias Koscielny, Arne Mustea, Alexander |
author_facet | Egger, Eva Katharina Sezer, Oezge Condic, Mateja Recker, Florian Marinova, Milka Hilbert, Tobias Koscielny, Arne Mustea, Alexander |
author_sort | Egger, Eva Katharina |
collection | PubMed |
description | Femoral nerve palsy and meralgia paresthetica following gynecologic cancer surgery are rare, but severe and long lasting. Here, we aimed to study their incidence, severity, possible risk factors and its time to remission. Between January 2008 and December 2017 976 gynecologic cancer patients were identified in our institutional database receiving surgery. Complete patient charts were reviewed retrospectively. Possible risk factors were analyzed by Fisher’s exact test. 441 (45.18%) out 976 were treated for Ovarian cancer. In total 23 patients were identified with a postoperative neurological leg disorder. A femoral nerve palsy was present in 15 patients (1.5%) and a meralgia paresthetica in 8 patients (0.82%). Three patients showed both disorders. Duration of surgery (p = 0.0000), positioning during surgery (p = 0.0040), femoral artery catheter (p = 0.0051), prior chemotherapy (p = 0.0007), nicotine abuse (p = 0.00456) and prior polyneuropathy (p = 0.0181) showed a significant association with a postoperative femoral nerve palsy. Nicotine abuse (p = 0.0335) and prior chemotherapy (p = 0.0151) were significant for the development of a meralgia paresthetica. Long lasting surgery, patient positioning and femoral arterial catheter placement are risk factors for a postoperative femoral nerve palsy in gynecologic cancer surgery. Polyneuropathy, nicotine abuse, and prior chemotherapy are predisposing risk factors for a femoral nerve palsy and a meralgia paresthetica. A resolution of symptoms is the rule for both disorders within different time schedules. |
format | Online Article Text |
id | pubmed-9655817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96558172022-11-15 Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery Egger, Eva Katharina Sezer, Oezge Condic, Mateja Recker, Florian Marinova, Milka Hilbert, Tobias Koscielny, Arne Mustea, Alexander J Clin Med Article Femoral nerve palsy and meralgia paresthetica following gynecologic cancer surgery are rare, but severe and long lasting. Here, we aimed to study their incidence, severity, possible risk factors and its time to remission. Between January 2008 and December 2017 976 gynecologic cancer patients were identified in our institutional database receiving surgery. Complete patient charts were reviewed retrospectively. Possible risk factors were analyzed by Fisher’s exact test. 441 (45.18%) out 976 were treated for Ovarian cancer. In total 23 patients were identified with a postoperative neurological leg disorder. A femoral nerve palsy was present in 15 patients (1.5%) and a meralgia paresthetica in 8 patients (0.82%). Three patients showed both disorders. Duration of surgery (p = 0.0000), positioning during surgery (p = 0.0040), femoral artery catheter (p = 0.0051), prior chemotherapy (p = 0.0007), nicotine abuse (p = 0.00456) and prior polyneuropathy (p = 0.0181) showed a significant association with a postoperative femoral nerve palsy. Nicotine abuse (p = 0.0335) and prior chemotherapy (p = 0.0151) were significant for the development of a meralgia paresthetica. Long lasting surgery, patient positioning and femoral arterial catheter placement are risk factors for a postoperative femoral nerve palsy in gynecologic cancer surgery. Polyneuropathy, nicotine abuse, and prior chemotherapy are predisposing risk factors for a femoral nerve palsy and a meralgia paresthetica. A resolution of symptoms is the rule for both disorders within different time schedules. MDPI 2022-10-22 /pmc/articles/PMC9655817/ /pubmed/36362470 http://dx.doi.org/10.3390/jcm11216242 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Egger, Eva Katharina Sezer, Oezge Condic, Mateja Recker, Florian Marinova, Milka Hilbert, Tobias Koscielny, Arne Mustea, Alexander Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery |
title | Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery |
title_full | Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery |
title_fullStr | Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery |
title_full_unstemmed | Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery |
title_short | Postoperative Femoral Nerve Palsy and Meralgia Paresthetica after Gynecologic Oncologic Surgery |
title_sort | postoperative femoral nerve palsy and meralgia paresthetica after gynecologic oncologic surgery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655817/ https://www.ncbi.nlm.nih.gov/pubmed/36362470 http://dx.doi.org/10.3390/jcm11216242 |
work_keys_str_mv | AT eggerevakatharina postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery AT sezeroezge postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery AT condicmateja postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery AT reckerflorian postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery AT marinovamilka postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery AT hilberttobias postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery AT koscielnyarne postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery AT musteaalexander postoperativefemoralnervepalsyandmeralgiaparestheticaaftergynecologiconcologicsurgery |